What is ATON's earnings growth forecast for 2026-2026?
(NASDAQ: ATON) Alphaton Capital's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Alphaton Capital's earnings in 2026 is -$14,894,000.
In 2026, ATON is forecast to generate -$3,043,966 in earnings, with the lowest earnings forecast at -$2,924,594 and the highest earnings forecast at -$3,133,494.
What is ATON's revenue growth forecast for 2026-2026?
(NASDAQ: ATON) Alphaton Capital's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Alphaton Capital's revenue in 2026 is $0.
In 2026, ATON is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is ATON's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: ATON) forecast ROA is -9.95%, which is lower than the forecast US Biotechnology industry average of 17.14%.
What is ATON's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: ATON) Alphaton Capital's current Earnings Per Share (EPS) is -$8.01. In 2026, ATON's EPS is forecast to hit -$0.53 (min: -$0.51, max: -$0.55).
What is ATON's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: ATON) forecast ROE is -31.75%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.